Page results
-
UCLH is the only Supra-Centre in England to deliver Intracranial Stereotactic Radiosurgery and Stereotactic Radiotherapy Services (SRS/SRT) as part of an integrated neurosurgical and Neuro-oncology service to patients.
-
At UCLH, we encourage self-referral to our antenatal service, but you also have the choice to go via your GP who will make the referral for you.
-
We run two separate Urogynaecology services at UCH: The Urogynaecology and Pelvic Floor Unit and The Female Pelvic Medicine and Reconstructive Surgery Unit.
-
The reproductive medicine unit offers a comprehensive range of investigations and treatments for couples presenting with fertility problems, recurrent miscarriage and reproductive endocrinology.
-
First Seizure Clinic patient information leaflet
-
This page has been written for patients who are having radiotherapy for bone pain.
-
This page explains how our plasma cell multidisciplinary team (MDT) will support you during treatmen
-
Information for UCLH patients requiring complex congenital gynaecology or with differences of sex development.
-
This information page has been written to help answer some of the questions you may have about brain metastases, and their treatment with this specialised radiotherapy technique.
-
This information is for patients who are about to start a course of radiotherapy to the prostate/prostate bed.
File results
-
FOI/2022/0546 - Metastatic Cholangiocarcinoma (CCA) or Acute myeloid leukaemia
-
FOI/2022/0548 - Biologic and biosimilar products within Rheumatology
-
FOI/2022/0549 - SACT (systemic anti-cancer therapy) /cervical cancer treatments
-
FOI/2022/0550 - Patients that have been treated for glioblastoma brain cancer
-
FOI/2022/0553 - Patients tested for non-small cell lung cancer biomarkers
-
FOI/2022/0561 - Regulation (EU) 2016/425 Declarations of Conformity for all type IIR surgical masks provided as PPE to staff
-
FOI/2022/0571 - Treatment for biologic medicines in Dermatology
-
FOI/2022/0572 - Treatments for Hidradenitis Suppurativa and Psoriasis
-
FOI/2022/0573 - Use of WhatsApp by or within the Trust
-
FOI/2022/0513 - Myelofibrosis treatment